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Amelogenesis Imperfecta (AI) Screen development Research benefits of testing
Our smile is central to the
way we present ourselves
to the world. 
AI is the result of a group
of rare inherited diseases
of enamel formation.
It causes discoloured, misshapen, brittle or sometimes soft 
teeth. Patients experience pain, frequent infections and 
early tooth loss.
They also suffer from high
levels of distress, social
avoidance, and emotional
problems.
Defects in many different genes can cause AI, and the 
resulting enamel defects are highly variable.
We have developed a screening method that allows 
simultaneous screening of all AI genes, in hundreds of 
patients, cheaply in one test.
We have successfully screened 20 patients, and are 
ready to screen DNA from over 300 new AI patients 
already recruited from centres around the UK.
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Helps to uncover all the genes 
and mutations involved in AI.
Gives us a better 
understanding of how teeth 
form, relevant to other 
common enamel problems.
Clinical benefits of testing
Improved patients pathways lead to better care for all by 
raising standards and development of new treatments.
Gives patients and their
families information about
future risks and outcomes.
Means patients can be given a 
personalised treatment that is 
best for them.
AI usually means lots of trips to dentist throughout 
childhood. Having AI can be tough.
